Clinical Trial Update: Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating certolizumab for Crohn's disease with draining fistulas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma | Conditions: Crohn Disease | Phase 3 | Status: WITHDRAWN